Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 5, 2002, Pages 1180-1185

  McQuellon, Richard P ^a,d   Moose, Dawn B ^b   Russell, Gregory B ^a   Case, L Douglas ^a   Greven, Katherine ^a   Stevens, Michael ^c   Shaw, Edward G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Forsyth Regional Cancer Center   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Megestrol acetate; Quality of life

Indexed keywords

BRAIN; CHEMOTHERAPY; PATIENT MONITORING; TUMORS;

LUNG CANCER PATIENTS;

RADIOTHERAPY;

MEGESTROL ACETATE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEEDING BEHAVIOR; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NONHUMAN; NUTRITIONAL STATUS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADULT; AGED; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MEGESTROL ACETATE; MIDDLE AGED; QUALITY OF LIFE; WEIGHT LOSS;

EID: 0036535377     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02782-1     Document Type: Article

References (19)

1. Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy
2. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer; A North Central Cancer Treatment Group study
3. Weight changes in women with metastatic breast cancer treated with megestrol acetate; A comparison of standard versus high-dose therapy
4. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B
5. Appetite stimulation and weight gain with megestrol acetate
6. Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection
7. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients
8. Geriatric cachexia; The role of cytokines
9. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
10. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer
11. On appetite and its loss
12. Effectiveness of megestrol acetate in patients with advanced cancer; A randomized, double-blind, crossover study
13. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer; A randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group
14. Quality of life in cancer; Definition, purpose, and method of measurement
15. The Functional Assessment of Cancer Therapy scale; Development and validation of the general measure
16. Appraisal of methods for the study of chemotherapy of cancer in man; Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
17. Anorexia in the terminally ill cancer patient; The emotional impact on the patient and the family
18. Nutrition and hydration in the terminally ill cancer patient; The nurse's role in helping patients and families cope